194 related articles for article (PubMed ID: 1331628)
61. Cyproheptadine may act at the pituitary in Cushing's disease: evidence from CRF stimulation.
Tucci JR; Nowakowski KJ; Jackson IM
J Endocrinol Invest; 1989 Mar; 12(3):197-200. PubMed ID: 2542391
[TBL] [Abstract][Full Text] [Related]
62. Pitfalls in the diagnosis and management of Cushing's syndrome.
Bansal V; El Asmar N; Selman WR; Arafah BM
Neurosurg Focus; 2015 Feb; 38(2):E4. PubMed ID: 25639322
[TBL] [Abstract][Full Text] [Related]
63. Cushing's disease: clinical manifestations and diagnostic evaluation.
Kirk LF; Hash RB; Katner HP; Jones T
Am Fam Physician; 2000 Sep; 62(5):1119-27, 1133-4. PubMed ID: 10997535
[TBL] [Abstract][Full Text] [Related]
64. New diagnostic criteria of adrenal subclinical Cushing's syndrome: opinion from the Japan Endocrine Society.
Yanase T; Oki Y; Katabami T; Otsuki M; Kageyama K; Tanaka T; Kawate H; Tanabe M; Doi M; Akehi Y; Ichijo T
Endocr J; 2018 Apr; 65(4):383-393. PubMed ID: 29576599
[TBL] [Abstract][Full Text] [Related]
65. [Salivary cortisol in adrenal diseases].
Løvås K; Husebye ES
Tidsskr Nor Laegeforen; 2007 Mar; 127(6):730-2. PubMed ID: 17363984
[TBL] [Abstract][Full Text] [Related]
66. Metabolic changes in serum steroids for diagnosing and subtyping Cushing's syndrome.
Ahn CH; Lee C; Shim J; Kong SH; Kim SJ; Kim YH; Lee KE; Shin CS; Kim JH; Choi MH
J Steroid Biochem Mol Biol; 2021 Jun; 210():105856. PubMed ID: 33647522
[TBL] [Abstract][Full Text] [Related]
67. Diagnostic value of the simultaneous determination of urinary free and conjugated cortisol in Cushing's syndrome.
Pinsker P; Bultasová H; Svobodová J
Acta Endocrinol (Copenh); 1968 Jun; 58(2):183-90. PubMed ID: 4298201
[No Abstract] [Full Text] [Related]
68. ACTH-independent Cushing's syndrome in pregnancy with spontaneous resolution after delivery: control of the hypercortisolism with metyrapone.
Close CF; Mann MC; Watts JF; Taylor KG
Clin Endocrinol (Oxf); 1993 Sep; 39(3):375-9. PubMed ID: 8222300
[TBL] [Abstract][Full Text] [Related]
69. Adrenal dysfunction: test strategies for diagnosis.
Burke MD
Postgrad Med; 1981 Jan; 69(1):155-9, 162-4, 167-70. PubMed ID: 7465450
[TBL] [Abstract][Full Text] [Related]
70. Iatrogenic Cushing's disease in a boy after misdiagnosis of salt-losing virilizing adrenal hyperplasia: impaired metyrapone response with failure of catch-up growth.
Mendilaharzu H; Gregory T; Gardner LI
J Pediatr; 1973 Jul; 83(1):69-76. PubMed ID: 4358656
[No Abstract] [Full Text] [Related]
71. Pre-clinical Cushing's syndrome with body weight loss and normal circadian rhythm of blood pressure.
Iwami T; Nakamura T; Niwamae N; Yamagishi T; Utsugi T; Nagai R
Intern Med; 1998 Jun; 37(6):528-33. PubMed ID: 9678687
[TBL] [Abstract][Full Text] [Related]
72. Dynamic testing in Cushing's syndrome.
Kola B; Grossman AB
Pituitary; 2008; 11(2):155-62. PubMed ID: 18034306
[TBL] [Abstract][Full Text] [Related]
73. The metyrapone and dexamethasone suppression tests for the differential diagnosis of the adrenocorticotropin-dependent Cushing syndrome: a comparison.
Avgerinos PC; Yanovski JA; Oldfield EH; Nieman LK; Cutler GB
Ann Intern Med; 1994 Sep; 121(5):318-27. PubMed ID: 8042820
[TBL] [Abstract][Full Text] [Related]
74. Laboratory evaluation of disorders of the adrenal cortex.
Tyler FH; West CD
Am J Med; 1972 Nov; 53(5):664-72. PubMed ID: 4342889
[No Abstract] [Full Text] [Related]
75. Preclinical Cushing's syndrome: report of seven cases and a review of the literature.
Morioka M; Fujii T; Matsuki T; Jo Y; Kobayashi T; Tanaka H; Ohashi T; Kondo K
Int J Urol; 2000 Apr; 7(4):126-32. PubMed ID: 10810968
[TBL] [Abstract][Full Text] [Related]
76. The combined use of sodium valproate and metyrapone in the treatment of Cushing's syndrome.
Nussey SS; Price P; Jenkins JS; Altaher AR; Gillham B; Jones MT
Clin Endocrinol (Oxf); 1988 Apr; 28(4):373-80. PubMed ID: 2847889
[TBL] [Abstract][Full Text] [Related]
77. A cluster of cases of factitious Cushing's syndrome.
Villanueva RB; Brett E; Gabrilove JL
Endocr Pract; 2000; 6(2):143-7. PubMed ID: 11421530
[TBL] [Abstract][Full Text] [Related]
78. New causes of Cushing's syndrome: abnormal adrenal regulation of cortisol production.
Atkinson AB
Clin Endocrinol (Oxf); 2000 Feb; 52(2):137. PubMed ID: 10671937
[No Abstract] [Full Text] [Related]
79. Remission of Cushing's disease after administration of adrenocorticotropin.
Pratt JH; Sawin CT; Melby JC
Am J Med; 1974 Dec; 57(6):949-52. PubMed ID: 4139895
[No Abstract] [Full Text] [Related]
80. [Clinical characteristics of 16 patients suspected preclinical Cushing's syndrome].
Koide H; Furuta N; Yamada H; Ito H; Kishimoto K; Ikemoto I; Oishi Y
Nihon Hinyokika Gakkai Zasshi; 2004 Jan; 95(1):1-7. PubMed ID: 14978935
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
